Acylation and carbanilation of cellulose in ionic liquids
By S. Barthel, T. Heinze. 2006
361 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Catalysis
View Paper: https://www.semanticscholar.org/paper/37c926d564d3c95a5a5149291c31beb7c8df083c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
In Catalysis
Citations in the corpus
- Ionic Liquids: Applications and Perspectives (2011, background): “…as reaction media for cellulose modification with other liquid reagents, such as carbanilation with phenyl isocyanate (Barthel & Heinze, 2006; Schlufter et al., 2006), acylation with lauroyl chloride (Barthel & Heinze, 2006), and perpropionylation with propionic anhydride (Schlufter et al., 2006).”
- Dissolution and forming of cellulose with ionic liquids (2008, background): “Also the suitability of ionic liquids for the dissolution of cellulose was the subject of various investigations by a growing number of working groups (Swatlowski et al. 2003; Laus et al. 2005; Zhu et al. 2006; Barthel and Heinze 2006 ).”
- Dissolution Behavior of Chitin in Ionic Liquids (2010, background): “[26–28] It was found that ionic liquids (ILs) such as alkylimidazolium chloride,[29,30] alkylpyridinium chloride,[31] alkylimidazolium carboxylates,[32] and alkylimidazolium dialkyl phosphate[33] can dissolve cellulose in high concentrations without derivatization.”
- Interaction of ionic liquids with polysaccharides. 5. Solvents and reaction media for the modification of cellulose (2008, background): “An alternative path would be the use of cellulose solvents with an addtional alkyl function at position 2, e.g. ADMIMBr (10, Barthel and Heinze 2006) and BDMIMCl (9, Kosan et al. 2008).”
- Cellulose: Structure and Properties (2015, background): “Dissolution of cellulose in pyridinium salts must be performed under protective gas otherwise degradation results [128] 1-Ethyl-3-methylimidazolium acetate (EMIMAc) ILs have the advantage of not having a reactive side group, such as the unsaturated function of the 1-allyl-3methylimidazolium (AMIM) i”